AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SITAGLIPTIN+METFORMIN

10 registrations across 2 African markets— 10 active

Markets with SITAGLIPTIN+METFORMIN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Duvel Plus Tablet 50 + 1000mg
Coated Tablet
🇰🇪KenyaMARTIN DOW LIMITEDactiveMar 2028
Duvel Plus Tablet 50 + 500mg
Coated Tablet
🇰🇪KenyaMARTIN DOW LIMITEDactiveMar 2028
QSita-M 50mg/1000mg Tablet
Tablet
🇰🇪KenyaQ PHARMA DMCCactiveApr 2027
QSita-M 50mg/ 500mg Tablet
Tablet
🇰🇪KenyaQ PHARMA DMCCactiveApr 2027
Jentin Met Tablets 50/500mg
Tablet
🇰🇪KenyaTHE SEARLE COMPANY LIMITEDactiveSept 2026
Jentin Met Tablets 50/1000mg
Tablet
🇰🇪KenyaTHE SEALE COMPANY LTDactiveSept 2026
TREVIAMET 50+500MG
COMPRIMES / 50MG+500 mg
🇸🇳SenegalGETZ PHARMAactive
TREVIAMET 50+1000MG
COMPRIMES / 50MG+10000 MG
🇸🇳SenegalGETZ PHARMAactive
TREVIAMET 50+1000MG
COMPRIMES / 50MG+10000 MG
🇸🇳SenegalGETZ PHARMAactive
TREVIAMET 50+500MG
COMPRIMES / 50MG+500 mg
🇸🇳SenegalGETZ PHARMAactive

SITAGLIPTIN+METFORMIN in Africa — Regulatory Overview

SITAGLIPTIN+METFORMIN is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.